We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CRDL Cardiol Therapeutics Inc

-0.0065 (-0.71%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 102,170
Bid Price 0.91
Ask Price 0.99
News -
Day High 0.93


52 Week Range


Day Low 0.91
Company Name Stock Ticker Symbol Market Type
Cardiol Therapeutics Inc CRDL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0065 -0.71% 0.91 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.91 0.91 0.93 0.93 0.9165
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
277 102,170 $ 0.9269968 $ 94,711 - 0.45 - 1.2353
Last Trade Time Type Quantity Stock Price Currency
17:29:41 formt 600 $ 0.91 USD

Cardiol Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
82.04M 65.11M - 0 -30.93M -0.48 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cardiol Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CRDL Message Board. Create One! See More Posts on CRDL Message Board See More Message Board Posts

Historical CRDL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.870.94730.85010.899534882,2950.044.6%
1 Month0.840.94730.720.839648298,9160.078.33%
3 Months1.001.070.6610.8786668224,847-0.09-9.0%
6 Months0.631.23530.630.9207118208,2690.2844.44%
1 Year0.511.23530.450.808293164,1990.4078.43%
3 Years2.634.960.452.11308,025-1.72-65.4%
5 Years2.634.960.452.11308,025-1.72-65.4%

Cardiol Therapeutics Description

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |